image
Cidara Therapeutics, Inc. CDTX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 14.37
-0.76 %
$ 101 M
Market Cap
-0.6
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -0.60% 23.05% 17.62%
Annual Report FY 10-K 2022-12-31 29.69% 32.13% 29.67%
Annual Report FY 10-K 2021-12-31 310.81% 39.33% 41.19%
Annual Report FY 10-K 2020-12-31 -42.30% -80.55% -72.20%
Annual Report FY 10-K 2019-12-31 0.00% 32.08% 34.07%
Annual Report FY 10-K 2018-12-31 0.00% -5.90% -13.57%
Annual Report FY 10-K 2017-12-31 0.00% -15.70% -15.04%
Annual Report FY 10-K 2016-12-31 0.00% -49.61% -49.90%
Annual Report FY 10-K 2015-12-31 0.00% -170.67% -178.01%
Annual Report FY 10-K 2014-12-31 0.00% -784.97% -974.21%
Annual Report FY 10-K 2013-12-31 0.00% -69.70% -36.62%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -90.10% -103.32%
Quarterly Report Q2 8-K 2024-06-30 -96.03% -623.56% 13.48%
Quarterly Report Q1 8-K 2024-03-31 -67.44% -342.71% -359.12%
Quarterly Report Q4 8-K 2023-12-31 72.06% 58.05% 54.22%
Quarterly Report Q3 8-K 2023-09-30 -68.79% -68.69% -57.33%
Quarterly Report Q2 8-K 2023-06-30 22.49% 5.85% 2.15%
Quarterly Report Q1 8-K 2023-03-31 265.59% 116.46% 116.30%
Quarterly Report Q4 8-K 2022-12-31 41.44% 20.39% 20.89%
Quarterly Report Q3 8-K 2022-09-30 475.81% 165.79% 182.74%
Quarterly Report Q2 8-K 2022-06-30 -81.09% -148.83% -121.72%
Quarterly Report Q1 8-K 2022-03-31 195.22% -0.05% -0.21%
Quarterly Report Q4 8-K 2021-12-31 93.75% 22.33% 22.17%
Quarterly Report Q3 8-K 2021-09-30 192.88% -2.56% -2.89%
Quarterly Report Q2 8-K 2021-06-30 868.84% 148.18% 159.16%
Quarterly Report Q1 8-K 2021-03-31 -4.82% -25.81% -25.14%
Quarterly Report Q4 8-K 2020-12-31 105.45% -54.28% -53.04%
Quarterly Report Q3 8-K 2020-09-30 -87.35% -679.46% -578.90%
Quarterly Report Q2 8-K 2020-06-30 0.00% -35.13% -27.64%
Quarterly Report Q1 8-K 2020-03-31 0.00% 12.21% 11.24%
Quarterly Report Q4 8-K 2019-12-31 0.00% -13.62% 15.17%
Quarterly Report Q3 8-K 2019-09-30 0.00% 119.05% 120.56%
Quarterly Report Q2 8-K 2019-06-30 0.00% 16.92% 5.83%
Quarterly Report Q1 8-K 2019-03-31 0.00% 1.12% 2.42%
Quarterly Report Q4 8-K 2018-12-31 0.00% 8.09% -23.32%
Quarterly Report Q3 8-K 2018-09-30 0.00% -11.11% -20.21%
Quarterly Report Q2 8-K 2018-06-30 0.00% 2.04% 8.81%
Quarterly Report Q1 8-K 2018-03-31 0.00% -25.01% -25.47%
Quarterly Report Q4 8-K 2017-12-31 0.00% 6.71% 6.23%
Quarterly Report Q3 8-K 2017-09-30 0.00% -0.25% 0.71%
Quarterly Report Q2 8-K 2017-06-30 0.00% -41.60% -40.07%
Quarterly Report Q1 8-K 2017-03-31 0.00% -36.87% -35.54%
Quarterly Report Q4 8-K 2016-12-31 0.00% -45.87% -44.57%
Quarterly Report Q3 8-K 2016-09-30 0.00% -33.28% -33.99%
Quarterly Report Q2 8-K 2016-06-30 0.00% -83.27% -84.02%
Quarterly Report Q1 8-K 2016-03-31 0.00% -45.30% -46.84%
Quarterly Report Q4 8-K 2015-12-31 0.00% -112.26% -113.55%
Quarterly Report Q3 8-K 2015-09-30 0.00% -176.41% -177.32%
Quarterly Report Q2 8-K 2015-06-30 0.00% -99.25% -108.27%
Quarterly Report Q1 8-K 2015-03-31 0.00% -852.90% -1104.29%
Quarterly Report Q4 8-K 2014-12-31 0.00% -1056.47% -1486.69%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%